English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA greater proportion of patients with severe, uncontrolled asthma had more significant clinical responses to tezepelumab than placebo, according to research published at the ATS 2022 international conference. The study showed that nearly half of those enrolled achieved complete response to treatment across measures of exacerbation reduction, asthma control, lung function, and clinician assessment.
Tag: uncontrolled asthma
New Study Shows Latinos with COVID-19 Had Higher Probability of Developing Asthma Exacerbations
A new study being presented at this year’s ACAAI Annual Scientific Meeting reveals Latinos with asthma were 4.6 times more likely than Blacks to develop asthma exacerbations (uncontrolled asthma) following COIVD-19, and 2.9 times more likely than whites.